 | • レポートコード：QYR2104Z3056 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、免疫情報のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（がん診断・治療、逆ワクチン、免疫系モデリング）、用途別市場規模（アレルギー予測データベース、分析リソースデータベース、国際免疫遺伝学システム、免疫エピトープオントロジー、免疫エピトープデータベース）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・免疫情報の市場動向 ・企業の競争状況、市場シェア ・免疫情報の種類別市場規模（がん診断・治療、逆ワクチン、免疫系モデリング） ・免疫情報の用途別市場規模（アレルギー予測データベース、分析リソースデータベース、国際免疫遺伝学システム、免疫エピトープオントロジー、免疫エピトープデータベース） ・免疫情報の北米市場規模2016-2027（アメリカ、カナダ） ・免疫情報のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・免疫情報のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・免疫情報の中南米市場規模2016-2027（メキシコ、ブラジル） ・免疫情報の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（EpiVax、Novozymes Biopharma、ioGenetics、International Society of Vaccines、IMGT、Dassault Systemes、Certara、Chemical Computing Group、Compugen、Genedata AG、Insilico Biotechnology AG、Leadscope Inc、Nimbus Discovery、Strand Life Sciences、Schrodinger、Simulation Plus、Rosa & Co） ・結論 |
Immunoinformatics is a field of science that encompasses high-throughput genomic and bioinformatics approaches to immunology. The field’s main aim is to convert immunological data into computational problems, solve these problems using mathematical and computational approaches and then convert these results into immunologically meaningful interpretations.
Market Analysis and Insights: Global Immunoinformatics Market
The global Immunoinformatics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Immunoinformatics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Immunoinformatics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Immunoinformatics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Immunoinformatics market.
Global Immunoinformatics Scope and Market Size
Immunoinformatics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Immunoinformatics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Cancer Diagnosis & Therapy
Reverse Vaccinology
Immune System Modeling
Segment by Application
Allergy Prediction Databases
Analysis Resource Database
International Immunogenetics System
The Ontology Of Immune Epitopes
Immune Epitope Database
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
EpiVax
Novozymes Biopharma
ioGenetics
International Society of Vaccines
IMGT
Dassault Systemes
Certara
Chemical Computing Group
Compugen
International Society of Vaccines
IMGT
Leadscope Inc
Nimbus Discovery
Strand Life Sciences
Schrodinger
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunoinformatics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cancer Diagnosis & Therapy
1.2.3 Reverse Vaccinology
1.2.4 Immune System Modeling
1.3 Market by Application
1.3.1 Global Immunoinformatics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Allergy Prediction Databases
1.3.3 Analysis Resource Database
1.3.4 International Immunogenetics System
1.3.5 The Ontology Of Immune Epitopes
1.3.6 Immune Epitope Database
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Immunoinformatics Market Perspective (2016-2027)
2.2 Immunoinformatics Growth Trends by Regions
2.2.1 Immunoinformatics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Immunoinformatics Historic Market Share by Regions (2016-2021)
2.2.3 Immunoinformatics Forecasted Market Size by Regions (2022-2027)
2.3 Immunoinformatics Industry Dynamic
2.3.1 Immunoinformatics Market Trends
2.3.2 Immunoinformatics Market Drivers
2.3.3 Immunoinformatics Market Challenges
2.3.4 Immunoinformatics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immunoinformatics Players by Revenue
3.1.1 Global Top Immunoinformatics Players by Revenue (2016-2021)
3.1.2 Global Immunoinformatics Revenue Market Share by Players (2016-2021)
3.2 Global Immunoinformatics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Immunoinformatics Revenue
3.4 Global Immunoinformatics Market Concentration Ratio
3.4.1 Global Immunoinformatics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunoinformatics Revenue in 2020
3.5 Immunoinformatics Key Players Head office and Area Served
3.6 Key Players Immunoinformatics Product Solution and Service
3.7 Date of Enter into Immunoinformatics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunoinformatics Breakdown Data by Type
4.1 Global Immunoinformatics Historic Market Size by Type (2016-2021)
4.2 Global Immunoinformatics Forecasted Market Size by Type (2022-2027)
5 Immunoinformatics Breakdown Data by Application
5.1 Global Immunoinformatics Historic Market Size by Application (2016-2021)
5.2 Global Immunoinformatics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Immunoinformatics Market Size (2016-2027)
6.2 North America Immunoinformatics Market Size by Type
6.2.1 North America Immunoinformatics Market Size by Type (2016-2021)
6.2.2 North America Immunoinformatics Market Size by Type (2022-2027)
6.2.3 North America Immunoinformatics Market Size by Type (2016-2027)
6.3 North America Immunoinformatics Market Size by Application
6.3.1 North America Immunoinformatics Market Size by Application (2016-2021)
6.3.2 North America Immunoinformatics Market Size by Application (2022-2027)
6.3.3 North America Immunoinformatics Market Size by Application (2016-2027)
6.4 North America Immunoinformatics Market Size by Country
6.4.1 North America Immunoinformatics Market Size by Country (2016-2021)
6.4.2 North America Immunoinformatics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Immunoinformatics Market Size (2016-2027)
7.2 Europe Immunoinformatics Market Size by Type
7.2.1 Europe Immunoinformatics Market Size by Type (2016-2021)
7.2.2 Europe Immunoinformatics Market Size by Type (2022-2027)
7.2.3 Europe Immunoinformatics Market Size by Type (2016-2027)
7.3 Europe Immunoinformatics Market Size by Application
7.3.1 Europe Immunoinformatics Market Size by Application (2016-2021)
7.3.2 Europe Immunoinformatics Market Size by Application (2022-2027)
7.3.3 Europe Immunoinformatics Market Size by Application (2016-2027)
7.4 Europe Immunoinformatics Market Size by Country
7.4.1 Europe Immunoinformatics Market Size by Country (2016-2021)
7.4.2 Europe Immunoinformatics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Immunoinformatics Market Size (2016-2027)
8.2 Asia-Pacific Immunoinformatics Market Size by Type
8.2.1 Asia-Pacific Immunoinformatics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Immunoinformatics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Immunoinformatics Market Size by Type (2016-2027)
8.3 Asia-Pacific Immunoinformatics Market Size by Application
8.3.1 Asia-Pacific Immunoinformatics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Immunoinformatics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Immunoinformatics Market Size by Application (2016-2027)
8.4 Asia-Pacific Immunoinformatics Market Size by Region
8.4.1 Asia-Pacific Immunoinformatics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Immunoinformatics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Immunoinformatics Market Size (2016-2027)
9.2 Latin America Immunoinformatics Market Size by Type
9.2.1 Latin America Immunoinformatics Market Size by Type (2016-2021)
9.2.2 Latin America Immunoinformatics Market Size by Type (2022-2027)
9.2.3 Latin America Immunoinformatics Market Size by Type (2016-2027)
9.3 Latin America Immunoinformatics Market Size by Application
9.3.1 Latin America Immunoinformatics Market Size by Application (2016-2021)
9.3.2 Latin America Immunoinformatics Market Size by Application (2022-2027)
9.3.3 Latin America Immunoinformatics Market Size by Application (2016-2027)
9.4 Latin America Immunoinformatics Market Size by Country
9.4.1 Latin America Immunoinformatics Market Size by Country (2016-2021)
9.4.2 Latin America Immunoinformatics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immunoinformatics Market Size (2016-2027)
10.2 Middle East & Africa Immunoinformatics Market Size by Type
10.2.1 Middle East & Africa Immunoinformatics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Immunoinformatics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Immunoinformatics Market Size by Type (2016-2027)
10.3 Middle East & Africa Immunoinformatics Market Size by Application
10.3.1 Middle East & Africa Immunoinformatics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Immunoinformatics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Immunoinformatics Market Size by Application (2016-2027)
10.4 Middle East & Africa Immunoinformatics Market Size by Country
10.4.1 Middle East & Africa Immunoinformatics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Immunoinformatics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 EpiVax
11.1.1 EpiVax Company Details
11.1.2 EpiVax Business Overview
11.1.3 EpiVax Immunoinformatics Introduction
11.1.4 EpiVax Revenue in Immunoinformatics Business (2016-2021)
11.1.5 EpiVax Recent Development
11.2 Novozymes Biopharma
11.2.1 Novozymes Biopharma Company Details
11.2.2 Novozymes Biopharma Business Overview
11.2.3 Novozymes Biopharma Immunoinformatics Introduction
11.2.4 Novozymes Biopharma Revenue in Immunoinformatics Business (2016-2021)
11.2.5 Novozymes Biopharma Recent Development
11.3 ioGenetics
11.3.1 ioGenetics Company Details
11.3.2 ioGenetics Business Overview
11.3.3 ioGenetics Immunoinformatics Introduction
11.3.4 ioGenetics Revenue in Immunoinformatics Business (2016-2021)
11.3.5 ioGenetics Recent Development
11.4 International Society of Vaccines
11.4.1 International Society of Vaccines Company Details
11.4.2 International Society of Vaccines Business Overview
11.4.3 International Society of Vaccines Immunoinformatics Introduction
11.4.4 International Society of Vaccines Revenue in Immunoinformatics Business (2016-2021)
11.4.5 International Society of Vaccines Recent Development
11.5 IMGT
11.5.1 IMGT Company Details
11.5.2 IMGT Business Overview
11.5.3 IMGT Immunoinformatics Introduction
11.5.4 IMGT Revenue in Immunoinformatics Business (2016-2021)
11.5.5 IMGT Recent Development
11.6 Dassault Systemes
11.6.1 Dassault Systemes Company Details
11.6.2 Dassault Systemes Business Overview
11.6.3 Dassault Systemes Immunoinformatics Introduction
11.6.4 Dassault Systemes Revenue in Immunoinformatics Business (2016-2021)
11.6.5 Dassault Systemes Recent Development
11.7 Certara
11.7.1 Certara Company Details
11.7.2 Certara Business Overview
11.7.3 Certara Immunoinformatics Introduction
11.7.4 Certara Revenue in Immunoinformatics Business (2016-2021)
11.7.5 Certara Recent Development
11.8 Chemical Computing Group
11.8.1 Chemical Computing Group Company Details
11.8.2 Chemical Computing Group Business Overview
11.8.3 Chemical Computing Group Immunoinformatics Introduction
11.8.4 Chemical Computing Group Revenue in Immunoinformatics Business (2016-2021)
11.8.5 Chemical Computing Group Recent Development
11.9 Compugen
11.9.1 Compugen Company Details
11.9.2 Compugen Business Overview
11.9.3 Compugen Immunoinformatics Introduction
11.9.4 Compugen Revenue in Immunoinformatics Business (2016-2021)
11.9.5 Compugen Recent Development
11.10 Genedata AG
11.10.1 Genedata AG Company Details
11.10.2 Genedata AG Business Overview
11.10.3 Genedata AG Immunoinformatics Introduction
11.10.4 Genedata AG Revenue in Immunoinformatics Business (2016-2021)
11.10.5 Genedata AG Recent Development
11.11 Insilico Biotechnology AG
11.11.1 Insilico Biotechnology AG Company Details
11.11.2 Insilico Biotechnology AG Business Overview
11.11.3 Insilico Biotechnology AG Immunoinformatics Introduction
11.11.4 Insilico Biotechnology AG Revenue in Immunoinformatics Business (2016-2021)
11.11.5 Insilico Biotechnology AG Recent Development
11.12 Leadscope Inc
11.12.1 Leadscope Inc Company Details
11.12.2 Leadscope Inc Business Overview
11.12.3 Leadscope Inc Immunoinformatics Introduction
11.12.4 Leadscope Inc Revenue in Immunoinformatics Business (2016-2021)
11.12.5 Leadscope Inc Recent Development
11.13 Nimbus Discovery
11.13.1 Nimbus Discovery Company Details
11.13.2 Nimbus Discovery Business Overview
11.13.3 Nimbus Discovery Immunoinformatics Introduction
11.13.4 Nimbus Discovery Revenue in Immunoinformatics Business (2016-2021)
11.13.5 Nimbus Discovery Recent Development
11.14 Strand Life Sciences
11.14.1 Strand Life Sciences Company Details
11.14.2 Strand Life Sciences Business Overview
11.14.3 Strand Life Sciences Immunoinformatics Introduction
11.14.4 Strand Life Sciences Revenue in Immunoinformatics Business (2016-2021)
11.14.5 Strand Life Sciences Recent Development
11.15 Schrodinger
11.15.1 Schrodinger Company Details
11.15.2 Schrodinger Business Overview
11.15.3 Schrodinger Immunoinformatics Introduction
11.15.4 Schrodinger Revenue in Immunoinformatics Business (2016-2021)
11.15.5 Schrodinger Recent Development
11.16 Simulation Plus
11.16.1 Simulation Plus Company Details
11.16.2 Simulation Plus Business Overview
11.16.3 Simulation Plus Immunoinformatics Introduction
11.16.4 Simulation Plus Revenue in Immunoinformatics Business (2016-2021)
11.16.5 Simulation Plus Recent Development
11.17 Rosa & Co
11.17.1 Rosa & Co Company Details
11.17.2 Rosa & Co Business Overview
11.17.3 Rosa & Co Immunoinformatics Introduction
11.17.4 Rosa & Co Revenue in Immunoinformatics Business (2016-2021)
11.17.5 Rosa & Co Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Immunoinformatics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cancer Diagnosis & Therapy
Table 3. Key Players of Reverse Vaccinology
Table 4. Key Players of Immune System Modeling
Table 5. Global Immunoinformatics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Immunoinformatics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Immunoinformatics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Immunoinformatics Market Share by Regions (2016-2021)
Table 9. Global Immunoinformatics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Immunoinformatics Market Share by Regions (2022-2027)
Table 11. Immunoinformatics Market Trends
Table 12. Immunoinformatics Market Drivers
Table 13. Immunoinformatics Market Challenges
Table 14. Immunoinformatics Market Restraints
Table 15. Global Immunoinformatics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Immunoinformatics Market Share by Players (2016-2021)
Table 17. Global Top Immunoinformatics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunoinformatics as of 2020)
Table 18. Ranking of Global Top Immunoinformatics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Immunoinformatics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Immunoinformatics Product Solution and Service
Table 22. Date of Enter into Immunoinformatics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Immunoinformatics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Immunoinformatics Revenue Market Share by Type (2016-2021)
Table 26. Global Immunoinformatics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Immunoinformatics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Immunoinformatics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Immunoinformatics Revenue Market Share by Application (2016-2021)
Table 30. Global Immunoinformatics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Immunoinformatics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Immunoinformatics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Immunoinformatics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Immunoinformatics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Immunoinformatics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Immunoinformatics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Immunoinformatics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Immunoinformatics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Immunoinformatics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Immunoinformatics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Immunoinformatics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Immunoinformatics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Immunoinformatics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Immunoinformatics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Immunoinformatics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Immunoinformatics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Immunoinformatics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Immunoinformatics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Immunoinformatics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Immunoinformatics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Immunoinformatics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Immunoinformatics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Immunoinformatics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Immunoinformatics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Immunoinformatics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Immunoinformatics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Immunoinformatics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Immunoinformatics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Immunoinformatics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Immunoinformatics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Immunoinformatics Market Size by Country (2022-2027) & (US$ Million)
Table 62. EpiVax Company Details
Table 63. EpiVax Business Overview
Table 64. EpiVax Immunoinformatics Product
Table 65. EpiVax Revenue in Immunoinformatics Business (2016-2021) & (US$ Million)
Table 66. EpiVax Recent Development
Table 67. Novozymes Biopharma Company Details
Table 68. Novozymes Biopharma Business Overview
Table 69. Novozymes Biopharma Immunoinformatics Product
Table 70. Novozymes Biopharma Revenue in Immunoinformatics Business (2016-2021) & (US$ Million)
Table 71. Novozymes Biopharma Recent Development
Table 72. ioGenetics Company Details
Table 73. ioGenetics Business Overview
Table 74. ioGenetics Immunoinformatics Product
Table 75. ioGenetics Revenue in Immunoinformatics Business (2016-2021) & (US$ Million)
Table 76. ioGenetics Recent Development
Table 77. International Society of Vaccines Company Details
Table 78. International Society of Vaccines Business Overview
Table 79. International Society of Vaccines Immunoinformatics Product
Table 80. International Society of Vaccines Revenue in Immunoinformatics Business (2016-2021) & (US$ Million)
Table 81. International Society of Vaccines Recent Development
Table 82. IMGT Company Details
Table 83. IMGT Business Overview
Table 84. IMGT Immunoinformatics Product
Table 85. IMGT Revenue in Immunoinformatics Business (2016-2021) & (US$ Million)
Table 86. IMGT Recent Development
Table 87. Dassault Systemes Company Details
Table 88. Dassault Systemes Business Overview
Table 89. Dassault Systemes Immunoinformatics Product
Table 90. Dassault Systemes Revenue in Immunoinformatics Business (2016-2021) & (US$ Million)
Table 91. Dassault Systemes Recent Development
Table 92. Certara Company Details
Table 93. Certara Business Overview
Table 94. Certara Immunoinformatics Product
Table 95. Certara Revenue in Immunoinformatics Business (2016-2021) & (US$ Million)
Table 96. Certara Recent Development
Table 97. Chemical Computing Group Company Details
Table 98. Chemical Computing Group Business Overview
Table 99. Chemical Computing Group Revenue in Immunoinformatics Business (2016-2021) & (US$ Million)
Table 100. Chemical Computing Group Recent Development
Table 101. Compugen Company Details
Table 102. Compugen Business Overview
Table 103. Compugen Immunoinformatics Product
Table 104. Compugen Revenue in Immunoinformatics Business (2016-2021) & (US$ Million)
Table 105. Compugen Recent Development
Table 106. Genedata AG Company Details
Table 107. Genedata AG Business Overview
Table 108. Genedata AG Immunoinformatics Product
Table 109. Genedata AG Revenue in Immunoinformatics Business (2016-2021) & (US$ Million)
Table 110. Genedata AG Recent Development
Table 111. Insilico Biotechnology AG Company Details
Table 112. Insilico Biotechnology AG Business Overview
Table 113. Insilico Biotechnology AG Immunoinformatics Product
Table 114. Insilico Biotechnology AG Revenue in Immunoinformatics Business (2016-2021) & (US$ Million)
Table 115. Insilico Biotechnology AG Recent Development
Table 116. Leadscope Inc Company Details
Table 117. Leadscope Inc Business Overview
Table 118. Leadscope Inc Immunoinformatics Product
Table 119. Leadscope Inc Revenue in Immunoinformatics Business (2016-2021) & (US$ Million)
Table 120. Leadscope Inc Recent Development
Table 121. Nimbus Discovery Company Details
Table 122. Nimbus Discovery Business Overview
Table 123. Nimbus Discovery Immunoinformatics Product
Table 124. Nimbus Discovery Revenue in Immunoinformatics Business (2016-2021) & (US$ Million)
Table 125. Nimbus Discovery Recent Development
Table 126. Strand Life Sciences Company Details
Table 127. Strand Life Sciences Business Overview
Table 128. Strand Life Sciences Immunoinformatics Product
Table 129. Strand Life Sciences Revenue in Immunoinformatics Business (2016-2021) & (US$ Million)
Table 130. Strand Life Sciences Recent Development
Table 131. Schrodinger Company Details
Table 132. Schrodinger Business Overview
Table 133. Schrodinger Immunoinformatics Product
Table 134. Schrodinger Revenue in Immunoinformatics Business (2016-2021) & (US$ Million)
Table 135. Schrodinger Recent Development
Table 136. Simulation Plus Company Details
Table 137. Simulation Plus Business Overview
Table 138. Simulation Plus Immunoinformatics Product
Table 139. Simulation Plus Revenue in Immunoinformatics Business (2016-2021) & (US$ Million)
Table 140. Simulation Plus Recent Development
Table 141. Rosa & Co Company Details
Table 142. Rosa & Co Business Overview
Table 143. Rosa & Co Immunoinformatics Product
Table 144. Rosa & Co Revenue in Immunoinformatics Business (2016-2021) & (US$ Million)
Table 145. Rosa & Co Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immunoinformatics Market Share by Type: 2020 VS 2027
Figure 2. Cancer Diagnosis & Therapy Features
Figure 3. Reverse Vaccinology Features
Figure 4. Immune System Modeling Features
Figure 5. Global Immunoinformatics Market Share by Application: 2020 VS 2027
Figure 6. Allergy Prediction Databases Case Studies
Figure 7. Analysis Resource Database Case Studies
Figure 8. International Immunogenetics System Case Studies
Figure 9. The Ontology Of Immune Epitopes Case Studies
Figure 10. Immune Epitope Database Case Studies
Figure 11. Immunoinformatics Report Years Considered
Figure 12. Global Immunoinformatics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Immunoinformatics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Immunoinformatics Market Share by Regions: 2020 VS 2027
Figure 15. Global Immunoinformatics Market Share by Regions (2022-2027)
Figure 16. Global Immunoinformatics Market Share by Players in 2020
Figure 17. Global Top Immunoinformatics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunoinformatics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Immunoinformatics Revenue in 2020
Figure 19. Global Immunoinformatics Revenue Market Share by Type (2016-2021)
Figure 20. Global Immunoinformatics Revenue Market Share by Type (2022-2027)
Figure 21. North America Immunoinformatics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Immunoinformatics Market Share by Type (2016-2027)
Figure 23. North America Immunoinformatics Market Share by Application (2016-2027)
Figure 24. North America Immunoinformatics Market Share by Country (2016-2027)
Figure 25. United States Immunoinformatics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Immunoinformatics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Immunoinformatics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Immunoinformatics Market Share by Type (2016-2027)
Figure 29. Europe Immunoinformatics Market Share by Application (2016-2027)
Figure 30. Europe Immunoinformatics Market Share by Country (2016-2027)
Figure 31. Germany Immunoinformatics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Immunoinformatics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Immunoinformatics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Immunoinformatics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Immunoinformatics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Immunoinformatics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Immunoinformatics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Immunoinformatics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Immunoinformatics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Immunoinformatics Market Share by Region (2016-2027)
Figure 41. China Immunoinformatics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Immunoinformatics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Immunoinformatics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Immunoinformatics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Immunoinformatics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Immunoinformatics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Immunoinformatics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Immunoinformatics Market Share by Type (2016-2027)
Figure 49. Latin America Immunoinformatics Market Share by Application (2016-2027)
Figure 50. Latin America Immunoinformatics Market Share by Country (2016-2027)
Figure 51. Mexico Immunoinformatics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Immunoinformatics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Immunoinformatics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Immunoinformatics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Immunoinformatics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Immunoinformatics Market Share by Country (2016-2027)
Figure 57. Turkey Immunoinformatics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Immunoinformatics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Immunoinformatics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. EpiVax Revenue Growth Rate in Immunoinformatics Business (2016-2021)
Figure 61. Novozymes Biopharma Revenue Growth Rate in Immunoinformatics Business (2016-2021)
Figure 62. ioGenetics Revenue Growth Rate in Immunoinformatics Business (2016-2021)
Figure 63. International Society of Vaccines Revenue Growth Rate in Immunoinformatics Business (2016-2021)
Figure 64. IMGT Revenue Growth Rate in Immunoinformatics Business (2016-2021)
Figure 65. Dassault Systemes Revenue Growth Rate in Immunoinformatics Business (2016-2021)
Figure 66. Certara Revenue Growth Rate in Immunoinformatics Business (2016-2021)
Figure 67. Chemical Computing Group Revenue Growth Rate in Immunoinformatics Business (2016-2021)
Figure 68. Compugen Revenue Growth Rate in Immunoinformatics Business (2016-2021)
Figure 69. Genedata AG Revenue Growth Rate in Immunoinformatics Business (2016-2021)
Figure 70. Insilico Biotechnology AG Revenue Growth Rate in Immunoinformatics Business (2016-2021)
Figure 71. Leadscope Inc Revenue Growth Rate in Immunoinformatics Business (2016-2021)
Figure 72. Nimbus Discovery Revenue Growth Rate in Immunoinformatics Business (2016-2021)
Figure 73. Strand Life Sciences Revenue Growth Rate in Immunoinformatics Business (2016-2021)
Figure 74. Schrodinger Revenue Growth Rate in Immunoinformatics Business (2016-2021)
Figure 75. Simulation Plus Revenue Growth Rate in Immunoinformatics Business (2016-2021)
Figure 76. Rosa & Co Revenue Growth Rate in Immunoinformatics Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
世界の計算免疫学市場規模・現状・予測（2021年-2027年） Computational Immunology is a field of science that encompasses high-throughput genomic and bioinformatics approaches to immunology. The field's main aim is to convert immunological data into computational problems, solve these problems using mathematical and computational approaches and then conver…- 世界の計算免疫学市場規模・現状・予測（2021年-2027年） Computational Immunology is a field of science that encompasses high-throughput genomic and bioinformatics approaches to immunology. The field's main aim is to convert immunological data into computational problems, solve these problems using mathematical and computational approaches and then conver…
- 世界の免疫システム用サプリメント市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Immune System Supplements Market The global Immune System Supplements market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, th…
- 世界の免疫システム用サプリメント市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Immune System Supplements Market The global Immune System Supplements market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, th…
- 世界の免疫レパートリーシーケンシング市場規模・現状・予測（2021年-2027年） Immune Repertoire is the collection of B and T cells with functional diversity in the body that reflects the immune selectivity. Immune Repertoire Sequencing means to sequence the complimentary determining region of both B-cell receptor and T-cell receptor. Immune receptor repertoire profiling portr…